Saudi Arabia Anticoagulants Market Size & Outlook
Saudi Arabia anticoagulants market, 2018-2030 (US$M)
Related Markets
Saudi Arabia anticoagulants market highlights
- The Saudi Arabia anticoagulants market generated a revenue of USD 128.5 million in 2023 and is expected to reach USD 213.1 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
- In terms of segment, novel oral anticoagulants (noacs) was the largest revenue generating drug category in 2023.
- Heparin and Low Molecular Weight Heparin (LMWH) is the most lucrative drug category segment registering the fastest growth during the forecast period.
Anticoagulants market data book summary
| Market revenue in 2023 | USD 128.5 million |
| Market revenue in 2030 | USD 213.1 million |
| Growth rate | 7.5% (CAGR from 2023 to 2030) |
| Largest segment | Novel oral anticoagulants (noacs) |
| Fastest growing segment | Heparin and Low Molecular Weight Heparin (LMWH) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Novel Oral Anticoagulants (NOACs), Vitamin K Antagonist, Direct Thrombin Inhibitors, Heparin and Low Molecular Weight Heparin (LMWH) |
| Key market players worldwide | Aspen Group Inc, Pfizer Inc, Bristol-Myers Squibb Co, GSK PLC, Sanofi SA, Bayer AG, Boehringer Ingelheim, Daiichi Sankyo Co Ltd, Johnson & Johnson, Eisai Co Ltd |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.4% of the global anticoagulants market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia anticoagulants market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 213.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anticoagulants Market Scope
Anticoagulants Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia anticoagulants market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulants market will help companies and investors design strategic landscapes.
Novel oral anticoagulants (noacs) was the largest segment with a revenue share of 57.28% in 2023. Horizon Databook has segmented the Saudi Arabia anticoagulants market based on novel oral anticoagulants (noacs), vitamin k antagonist, direct thrombin inhibitors, heparin and low molecular weight heparin (lmwh) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Saudi Arabia anticoagulants market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia anticoagulants market databook
-
Our clientele includes a mix of anticoagulants market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia anticoagulants market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia anticoagulants market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia anticoagulants market size, by drug category, 2018-2030 (US$M)
Saudi Arabia Anticoagulants Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
